Altimmune, Inc. (ALT) NASDAQ
$7.82 0.72 (10.09%)
Market Cap: $555.42M
As of 09/13/24 11:42 AM EDT. Market open.
Altimmune, Inc. (ALT)
NASDAQ
$7.82
0.72 (10.09%)
Market Cap: $555.42M
As of 09/13/24 11:42 AM EDT. Market open.
Add to Portfolio
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Vipin K. Garg Ph.D.
Full Time Employees
59
CEO Compensation (Base)
$620,154
CEO Compensation (Total)
$5.48M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Vipin K. Garg Ph.D.
Full Time Employees
59
CEO Compensation (Base)
$620,154
CEO Compensation (Total)
$5.48M
Address
910 Clopper Road, MD, Gaithersburg, 20878.
PRICE CHART FOR ALTIMMUNE, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.14
Previous Close
$7.10
Days Range
$7.14 - $7.85
52 week range
$2.09 - $14.84
Volume
1,527,170
Avg. Volume (30 days)
3,320,988
Market Cap
$555.42M
Dividend Yield
-
P/E
(4.79)
Shares Outstanding
71,070,900
Open
$7.14
Previous Close
$7.10
Days Range
$7.14 - $7.85
52 week range
$2.09 - $14.84
Volume
1,527,170
Avg. Volume (30 days)
3,320,988
Market Cap
$555.42M
Dividend Yield
-
P/E
(4.79)
Shares Outstanding
71,070,900
FINANCIAL STATEMENTS FOR ALTIMMUNE, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ALTIMMUNE, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Drutz David | Director | Aug 19, 2024 | Option Exercise | $2.55 | 41,750 | 106,375 | 63,708 | Aug 20, 2024, 06:05 PM |
| Drutz David | Director | Aug 19, 2024 | Sale | $6.90 | 16,011 | 110,547 | 55,524 | Aug 20, 2024, 06:05 PM |
| Shutterly Andrew | Acting Chief Financial Officer | Jul 31, 2024 | Option Exercise | $5.41 | 1,259 | 6,811 | 11,372 | Aug 01, 2024, 05:47 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 31, 2024 | Option Exercise | $5.41 | 650 | 3,516 | 43,310 | Aug 01, 2024, 05:45 PM |
| Jordt Raymond M | Chief Business Officer | Jul 31, 2024 | Option Exercise | $5.41 | 917 | 4,961 | 14,660 | Aug 01, 2024, 05:43 PM |
| Harris Matthew Scott | Chief Medical Officer | Jul 31, 2024 | Option Exercise | $5.41 | 1,486 | 8,039 | 55,119 | Aug 01, 2024, 05:40 PM |
| Roberts M Scot | Chief Scientific Officer | Feb 02, 2024 | Option Exercise | $9.32 | 2,330 | 21,716 | 42,660 | Feb 05, 2024, 06:02 PM |
| Roberts M Scot | Chief Scientific Officer | Feb 01, 2024 | Option Exercise | $9.88 | 1,801 | 17,794 | 37,215 | Feb 05, 2024, 06:02 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 02, 2024 | Option Exercise | $9.32 | 2,332 | 21,734 | 53,633 | Feb 05, 2024, 06:01 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 01, 2024 | Option Exercise | $9.88 | 1,801 | 17,794 | 48,190 | Feb 05, 2024, 06:01 PM |
| Garg Vipin K | President and CEO | Feb 01, 2024 | Option Exercise | $9.88 | 7,313 | 72,252 | 281,454 | Feb 05, 2024, 06:00 PM |
| Garg Vipin K | President and CEO | Feb 02, 2024 | Option Exercise | $9.32 | 8,376 | 78,064 | 292,028 | Feb 05, 2024, 06:00 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 31, 2024 | Option Exercise | $2.69 | 5,860 | 15,763 | 32,850 | Feb 01, 2024, 06:03 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 30, 2024 | Option Exercise | $9.80 | 2,709 | 26,548 | 26,990 | Feb 01, 2024, 06:03 PM |
| Jordt Raymond M | Chief Business Officer | Jan 31, 2024 | Option Exercise | $2.69 | 5,030 | 13,531 | 13,743 | Feb 01, 2024, 06:02 PM |
| Harris Matthew Scott | Chief Medical Officer | Jan 31, 2024 | Option Exercise | $2.69 | 3,257 | 8,761 | 43,825 | Feb 01, 2024, 06:01 PM |
| Harris Matthew Scott | Chief Medical Officer | Jan 30, 2024 | Option Exercise | $9.80 | 2,709 | 26,548 | 40,568 | Feb 01, 2024, 06:01 PM |
| Garg Vipin K | President and CEO | Jan 31, 2024 | Option Exercise | $2.69 | 7,889 | 21,221 | 272,222 | Feb 01, 2024, 06:01 PM |
| Garg Vipin K | President and CEO | Jan 30, 2024 | Option Exercise | $9.80 | 11,697 | 114,631 | 264,333 | Feb 01, 2024, 06:01 PM |
| Eisenstadt Richard I | Chief Financial Officer | Jan 31, 2024 | Option Exercise | $2.69 | 4,621 | 12,430 | 45,012 | Feb 01, 2024, 06:00 PM |
| Eisenstadt Richard I | Chief Financial Officer | Jan 30, 2024 | Option Exercise | $9.80 | 2,175 | 21,315 | 40,391 | Feb 01, 2024, 06:00 PM |
| Jordt Raymond M | Chief Business Officer | Jan 01, 2024 | Option Exercise | $11.25 | 2,503 | 28,159 | 8,704 | Jan 04, 2024, 06:00 PM |
| Eisenstadt Richard I | Chief Financial Officer | Dec 29, 2023 | Option Exercise | $11.25 | 3,044 | 34,245 | 33,291 | Jan 02, 2024, 06:00 PM |
| Drutz David | Director | Aug 15, 2023 | Buy | $2.88 | 300 | 863 | 29,785 | Aug 15, 2023, 06:46 PM |
| Garg Vipin K | President and CEO | Jul 31, 2023 | Option Exercise | $2.81 | 126 | 354 | 249,255 | Aug 02, 2023, 05:54 PM |
| Eisenstadt Richard I | Chief Financial Officer | Jul 31, 2023 | Option Exercise | $2.81 | 1,825 | 5,128 | 23,835 | Aug 02, 2023, 05:51 PM |
| Harris Matthew Scott | Chief Medical Officer | Jul 31, 2023 | Option Exercise | $2.81 | 691 | 1,942 | 34,002 | Aug 02, 2023, 05:49 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 31, 2023 | Option Exercise | $2.81 | 568 | 1,596 | 20,424 | Aug 02, 2023, 05:47 PM |
| Jordt Raymond M | Chief Business Officer | Jul 31, 2023 | Option Exercise | $2.81 | 1,832 | 5,148 | 1,832 | Aug 02, 2023, 05:43 PM |
| GILL JOHN | Director | Aug 12, 2022 | Sale | $15.00 | 2,714 | 40,710 | 2,771 | Jul 06, 2023, 06:00 PM |
| Drutz David | Director | Mar 23, 2023 | Buy | $4.27 | 9,000 | 38,430 | 29,484 | Mar 27, 2023, 05:17 PM |
| Eisenstadt Richard I | Chief Financial Officer | Mar 24, 2023 | Buy | $4.31 | 10,000 | 43,140 | 22,010 | Mar 24, 2023, 08:54 PM |
| Harris Matthew Scott | Chief Medical Officer | Mar 23, 2023 | Buy | $4.22 | 10,000 | 42,200 | 33,311 | Mar 23, 2023, 08:28 PM |
| Roberts M Scot | Chief Scientific Officer | Feb 02, 2023 | Option Exercise | $15.04 | 2,375 | 35,720 | 19,856 | Feb 06, 2023, 04:31 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 02, 2023 | Option Exercise | $15.04 | 2,364 | 35,555 | 23,311 | Feb 06, 2023, 04:31 PM |
| Garg Vipin K | President and CEO | Feb 02, 2023 | Option Exercise | $15.04 | 8,422 | 126,667 | 249,129 | Feb 06, 2023, 04:30 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 31, 2023 | Option Exercise | $10.21 | 1,436 | 14,659 | 10,473 | Feb 02, 2023, 05:11 PM |
| Roberts M Scot | Chief Scientific Officer | Feb 01, 2023 | Option Exercise | $13.78 | 2,183 | 30,082 | 14,456 | Feb 02, 2023, 05:11 PM |
| Harris Matthew Scott | Chief Medical Officer | Jan 31, 2023 | Option Exercise | $10.21 | 1,296 | 13,230 | 13,917 | Feb 02, 2023, 05:10 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 01, 2023 | Option Exercise | $13.78 | 2,183 | 30,082 | 17,900 | Feb 02, 2023, 05:10 PM |
| Garg Vipin K | President and CEO | Jan 31, 2023 | Option Exercise | $10.21 | 1,938 | 19,784 | 229,713 | Feb 02, 2023, 05:09 PM |
| Garg Vipin K | President and CEO | Feb 01, 2023 | Option Exercise | $13.78 | 7,658 | 105,527 | 238,601 | Feb 02, 2023, 05:09 PM |
| Eisenstadt Richard I | Chief Financial Officer | Jan 31, 2023 | Option Exercise | $10.21 | 1,172 | 11,964 | 12,010 | Feb 02, 2023, 05:09 PM |
| Eisenstadt Richard I | Chief Financial Officer | Dec 31, 2022 | Option Exercise | $16.45 | 3,028 | 49,811 | 10,838 | Jan 03, 2023, 05:59 PM |
| Pisano Wayne | Director | Dec 22, 2022 | Option Exercise | $2.60 | 20,000 | 52,000 | 28,498 | Dec 22, 2022, 04:05 PM |
| Pisano Wayne | Director | Dec 22, 2022 | Sale | $15.01 | 20,000 | 300,268 | 8,498 | Dec 22, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Nov 30, 2022 | Option Exercise | $9.95 | 3,007 | 29,920 | 227,775 | Dec 01, 2022, 04:05 PM |
| Drutz David | Director | Nov 18, 2022 | Option Exercise | $2.40 | 139 | 334 | 20,151 | Nov 21, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Oct 30, 2022 | Option Exercise | $12.77 | 3,007 | 38,399 | 230,782 | Oct 31, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Sep 30, 2022 | Option Exercise | $12.77 | 3,008 | 38,412 | 233,789 | Oct 03, 2022, 04:08 PM |
| Garg Vipin K | President and CEO | Aug 30, 2022 | Option Exercise | $18.94 | 3,007 | 56,953 | 256,797 | Sep 01, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Aug 31, 2022 | Sale | $20.02 | 20,000 | 400,322 | 236,797 | Sep 01, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Aug 12, 2022 | Sale | $15.06 | 15,000 | 225,890 | 259,804 | Aug 12, 2022, 07:55 PM |
| Harris Matthew Scott | Chief Medical Officer | Jul 31, 2022 | Option Exercise | $6.86 | 1,076 | 7,381 | 12,621 | Aug 03, 2022, 04:08 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 31, 2022 | Option Exercise | $6.86 | 732 | 5,022 | 9,037 | Aug 03, 2022, 04:06 PM |
| Eisenstadt Richard I | Chief Financial Officer | Jul 31, 2022 | Option Exercise | $6.86 | 1,366 | 9,371 | 1,366 | Aug 03, 2022, 04:05 PM |
| Garg Vipin K | President and CEO | Jul 30, 2022 | Option Exercise | $12.01 | 3,007 | 36,114 | 274,804 | Aug 01, 2022, 05:15 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 01, 2022 | Option Exercise | $2.90 | 26,982 | 78,190 | 44,682 | Jul 05, 2022, 05:15 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 05, 2022 | Option Exercise | $2.95 | 787 | 2,322 | 18,487 | Jul 05, 2022, 05:15 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 01, 2022 | Sale | $12.00 | 26,982 | 323,784 | 17,700 | Jul 05, 2022, 05:15 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 05, 2022 | Sale | $12.00 | 10,182 | 122,184 | 8,305 | Jul 05, 2022, 05:15 PM |
| Garg Vipin K | President and CEO | Jun 30, 2022 | Option Exercise | $11.70 | 3,007 | 35,182 | 277,811 | Jul 01, 2022, 04:17 PM |
| Roberts M Scot | Chief Scientific Officer | Jun 29, 2022 | Option Exercise | $2.60 | 5,462 | 14,201 | 23,162 | Jun 30, 2022, 04:05 PM |
| Roberts M Scot | Chief Scientific Officer | Jun 29, 2022 | Sale | $12.00 | 5,462 | 65,546 | 17,700 | Jun 30, 2022, 04:05 PM |
| Roberts M Scot | Chief Scientific Officer | Jun 27, 2022 | Option Exercise | $2.14 | 37,352 | 79,752 | 55,052 | Jun 28, 2022, 07:00 PM |
| Roberts M Scot | Chief Scientific Officer | Jun 27, 2022 | Sale | $12.00 | 37,352 | 448,254 | 17,700 | Jun 28, 2022, 07:00 PM |
| Jorkasky Diane | Director | Jun 27, 2022 | Option Exercise | $3.15 | 17,610 | 55,472 | 17,610 | Jun 28, 2022, 04:05 PM |
| Jorkasky Diane | Director | Jun 27, 2022 | Sale | $11.75 | 17,610 | 206,944 | 0 | Jun 28, 2022, 04:05 PM |
| Schafer Klaus | Director | Jun 20, 2022 | Option Exercise | $2.40 | 279 | 670 | 9,179 | Jun 22, 2022, 04:10 PM |
| Drutz David | Director | Jun 15, 2022 | Buy | $8.00 | 1,000 | 8,000 | 20,012 | Jun 16, 2022, 09:27 PM |
| Garg Vipin K | President and CEO | May 30, 2022 | Option Exercise | $5.03 | 3,008 | 15,130 | 280,818 | May 31, 2022, 07:00 PM |
| Drutz David | Director | May 24, 2022 | Buy | $4.50 | 1,200 | 5,400 | 19,012 | May 25, 2022, 07:00 PM |
| Garg Vipin K | President and CEO | Apr 30, 2022 | Option Exercise | $4.52 | 3,008 | 13,596 | 283,826 | May 02, 2022, 07:00 PM |
| Garg Vipin K | President and CEO | Mar 30, 2022 | Option Exercise | $6.05 | 3,007 | 18,192 | 286,834 | Mar 31, 2022, 07:00 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 28, 2022 | Option Exercise | $1.92 | 30,000 | 57,639 | 41,545 | Mar 02, 2022, 07:00 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 28, 2022 | Sale | $7.52 | 30,000 | 225,600 | 11,545 | Mar 02, 2022, 07:00 PM |
| Garg Vipin K | President and CEO | Feb 28, 2022 | Option Exercise | $7.41 | 3,007 | 22,282 | 289,841 | Mar 01, 2022, 07:01 PM |
| Harris Matthew Scott | Chief Medical Officer | Jan 31, 2022 | Option Exercise | $6.86 | 1,800 | 12,348 | 7,562 | Feb 03, 2022, 07:56 PM |
| Harris Matthew Scott | Chief Medical Officer | Feb 01, 2022 | Option Exercise | $7.98 | 2,183 | 17,420 | 11,545 | Feb 03, 2022, 07:56 PM |
| Garg Vipin K | President and CEO | Jan 31, 2022 | Option Exercise | $6.86 | 2,757 | 18,913 | 283,958 | Feb 03, 2022, 07:56 PM |
| Garg Vipin K | President and CEO | Feb 01, 2022 | Option Exercise | $7.98 | 7,655 | 61,087 | 292,848 | Feb 03, 2022, 07:56 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 31, 2022 | Option Exercise | $6.86 | 2,106 | 14,447 | 13,717 | Feb 03, 2022, 07:55 PM |
| Roberts M Scot | Chief Scientific Officer | Feb 01, 2022 | Option Exercise | $7.98 | 2,183 | 17,420 | 17,700 | Feb 03, 2022, 07:55 PM |
| Garg Vipin K | President and CEO | Jan 30, 2022 | Option Exercise | $7.20 | 2,355 | 16,956 | 281,201 | Jan 31, 2022, 07:01 PM |
| Drutz David | Director | Jan 25, 2022 | Option Exercise | $2.40 | 70 | 168 | 17,882 | Jan 26, 2022, 07:00 PM |
| Garg Vipin K | President and CEO | Dec 30, 2021 | Option Exercise | $8.93 | 3,007 | 26,853 | 283,556 | Jan 03, 2022, 07:00 PM |
| Drutz David | Director | Dec 14, 2021 | Option Exercise | $2.40 | 139 | 334 | 17,812 | Dec 15, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Nov 30, 2021 | Option Exercise | $10.49 | 3,007 | 31,543 | 286,563 | Dec 01, 2021, 07:00 PM |
| Drutz David | Director | Nov 19, 2021 | Option Exercise | $2.40 | 70 | 168 | 17,673 | Nov 19, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Oct 30, 2021 | Option Exercise | $10.80 | 3,007 | 32,476 | 289,570 | Nov 01, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Sep 30, 2021 | Option Exercise | $11.31 | 3,007 | 34,009 | 292,577 | Oct 01, 2021, 07:01 PM |
| Garg Vipin K | President and CEO | Aug 30, 2021 | Option Exercise | $14.09 | 3,008 | 42,383 | 295,584 | Aug 31, 2021, 07:00 PM |
| Harris Matthew Scott | Chief Medical Officer | Jul 31, 2021 | Option Exercise | $7.71 | 725 | 5,589 | 5,762 | Aug 06, 2021, 07:02 PM |
| Brown William Michael | Chief Financial Officer | Jul 31, 2021 | Option Exercise | $7.71 | 803 | 6,191 | 17,721 | Aug 06, 2021, 07:01 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 31, 2021 | Option Exercise | $7.71 | 1,750 | 13,492 | 11,611 | Aug 06, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Jul 30, 2021 | Option Exercise | $9.07 | 3,007 | 27,273 | 298,592 | Aug 02, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Jun 30, 2021 | Option Exercise | $9.85 | 3,007 | 29,619 | 301,599 | Jul 01, 2021, 07:01 PM |
| Garg Vipin K | President and CEO | Mar 30, 2021 | Option Exercise | $13.55 | 1,998 | 27,073 | 309,182 | Mar 31, 2021, 07:00 PM |
| Hodges Philip | Director | Mar 01, 2021 | Sale | $16.08 | 6,000 | 96,480 | 8,731 | Mar 01, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Feb 28, 2021 | Option Exercise | $15.94 | 1,998 | 31,848 | 311,180 | Mar 01, 2021, 07:00 PM |
| Harris Matthew Scott | Chief Medical Officer | Jan 31, 2021 | Option Exercise | $12.14 | 968 | 11,752 | 5,037 | Feb 03, 2021, 07:00 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 31, 2021 | Option Exercise | $12.14 | 467 | 5,669 | 9,861 | Feb 03, 2021, 07:00 PM |
| Brown William Michael | Chief Financial Officer | Jan 31, 2021 | Option Exercise | $12.14 | 937 | 11,375 | 16,918 | Feb 03, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Jan 31, 2021 | Option Exercise | $12.14 | 1,055 | 12,808 | 313,178 | Feb 03, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Jan 30, 2021 | Option Exercise | $14.28 | 2,353 | 33,601 | 312,123 | Feb 01, 2021, 07:00 PM |
| Garg Vipin K | President and CEO | Dec 30, 2020 | Option Exercise | $11.30 | 3,025 | 34,183 | 314,476 | Jan 04, 2021, 05:00 PM |
| Schafer Klaus | Director | Dec 10, 2020 | Buy | $11.99 | 2,000 | 23,980 | 8,900 | Dec 11, 2020, 07:00 PM |
| Hodges Philip | Director | Dec 01, 2020 | Sale | $13.54 | 1,227 | 16,614 | 0 | Dec 02, 2020, 07:05 PM |
| Hodges Philip | Director | Nov 30, 2020 | Sale | $12.00 | 2,500 | 30,000 | 14,731 | Dec 02, 2020, 07:05 PM |
| Garg Vipin K | President and CEO | Nov 30, 2020 | Option Exercise | $12.23 | 2,243 | 27,432 | 317,501 | Dec 02, 2020, 07:05 PM |
| GILL JOHN | Director | Nov 30, 2020 | Sale | $11.92 | 8,425 | 100,426 | 11,199 | Dec 02, 2020, 07:05 PM |
| Drutz David | Director | Nov 13, 2020 | Option Exercise | $2.40 | 60 | 144 | 17,603 | Nov 17, 2020, 07:00 PM |
| Schafer Klaus | Director | Nov 12, 2020 | Sale | $9.91 | 10,150 | 100,586 | 6,900 | Nov 13, 2020, 06:00 PM |
| Pisano Wayne | Director | Nov 12, 2020 | Sale | $9.90 | 10,352 | 102,485 | 8,498 | Nov 13, 2020, 06:00 PM |
| Harris Matthew Scott | Director | Nov 12, 2020 | Sale | $10.02 | 4,015 | 40,230 | 4,069 | Nov 13, 2020, 06:00 PM |
| Garg Vipin K | President and CEO | Oct 30, 2020 | Option Exercise | $11.45 | 2,015 | 23,072 | 319,744 | Nov 02, 2020, 06:00 PM |
| Garg Vipin K | President & CEO | Sep 30, 2020 | Option Exercise | $13.20 | 2,015 | 26,598 | 321,759 | Oct 02, 2020, 06:00 PM |
| Garg Vipin K | President & CEO | Aug 30, 2020 | Option Exercise | $17.62 | 2,015 | 35,504 | 323,774 | Aug 31, 2020, 06:01 PM |
| Harris Matthew Scott | Chief Medical Officer | Jul 31, 2020 | Option Exercise | $1.46 | 8,084 | 11,803 | 8,084 | Aug 04, 2020, 07:00 PM |
| Brown William Michael | Chief Financial Officer | Jul 31, 2020 | Option Exercise | $1.46 | 7,920 | 11,563 | 15,981 | Aug 04, 2020, 06:47 PM |
| Roberts M Scot | Chief Scientific Officer | Jul 31, 2020 | Option Exercise | $1.46 | 3,859 | 5,634 | 9,394 | Aug 04, 2020, 06:43 PM |
| Garg Vipin K | Chief Financial Officer | Jul 31, 2020 | Option Exercise | $1.46 | 11,674 | 17,044 | 325,789 | Aug 04, 2020, 06:40 PM |
| Garg Vipin K | President and CEO | Jul 30, 2020 | Option Exercise | $26.06 | 2,015 | 52,511 | 314,115 | Aug 03, 2020, 06:06 PM |
| Garg Vipin K | President and CEO | Jun 30, 2020 | Option Exercise | $10.71 | 2,015 | 21,581 | 316,130 | Jul 01, 2020, 06:02 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jun 15, 2020 | Buy | $7.54 | 1,500,000 | 11,310,000 | 4,500,000 | Jun 15, 2020, 03:23 PM |
| Garg Vipin K | President and CEO | May 30, 2020 | Option Exercise | $9.28 | 2,015 | 18,699 | 318,145 | Jun 02, 2020, 07:31 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | May 28, 2020 | Buy | $8.72 | 201,474 | 1,757,090 | 3,000,000 | May 28, 2020, 06:34 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | May 27, 2020 | Buy | $7.71 | 402,162 | 3,098,761 | 2,798,526 | May 28, 2020, 06:34 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | May 26, 2020 | Buy | $9.34 | 700,000 | 6,539,641 | 2,396,364 | May 28, 2020, 06:34 PM |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Owner | May 14, 2020 | Sale | $4.81 | 169,378 | 814,708 | 1,717,872 | May 18, 2020, 04:45 PM |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Owner | May 15, 2020 | Sale | $4.65 | 30,622 | 142,392 | 1,687,250 | May 18, 2020, 04:45 PM |
| Garg Vipin K | President and CEO | Apr 30, 2020 | Option Exercise | $3.05 | 2,015 | 6,146 | 320,160 | May 04, 2020, 06:00 PM |
| Garg Vipin K | President and CEO | Mar 31, 2020 | Option Exercise | $3.02 | 2,016 | 6,088 | 322,175 | Apr 01, 2020, 07:01 PM |
| Garg Vipin K | President and CEO | Feb 29, 2020 | Option Exercise | $3.70 | 2,015 | 7,456 | 324,191 | Mar 03, 2020, 06:01 PM |
| Brown William Michael | Chief Financial Officer | Jan 31, 2020 | Option Exercise | $1.46 | 8,061 | 11,769 | 8,061 | Feb 04, 2020, 08:34 PM |
| Garg Vipin K | President and CEO | Jan 31, 2020 | Option Exercise | $1.46 | 11,289 | 16,482 | 326,206 | Feb 04, 2020, 08:24 PM |
| Roberts M Scot | Chief Scientific Officer | Jan 31, 2020 | Option Exercise | $1.46 | 3,698 | 5,399 | 5,535 | Feb 04, 2020, 08:15 PM |
| Garg Vipin K | President and CEO | Jan 30, 2020 | Option Exercise | $1.77 | 2,015 | 3,567 | 314,917 | Feb 03, 2020, 07:36 PM |
| Garg Vipin K | President and CEO | Dec 30, 2019 | Option Exercise | $1.80 | 1,999 | 3,598 | 316,932 | Jan 02, 2020, 05:00 PM |
| Garg Vipin K | President and CEO | Nov 30, 2019 | Option Exercise | $1.82 | 23,976 | 43,636 | 318,931 | Dec 03, 2019, 07:00 PM |
| Garg Vipin K | President and CEO | Sep 05, 2019 | Buy | $2.10 | 20,000 | 42,000 | 342,907 | Sep 05, 2019, 05:04 PM |
| Pisano Wayne | Director | Oct 09, 2018 | Buy | $4.59 | 2,000 | 9,180 | 2,000 | Oct 11, 2018, 04:18 PM |
| Enright William | President and CEO | May 25, 2018 | Buy | $0.51 | 1,300 | 660 | 365,839 | May 29, 2018, 06:17 PM |
| Roberts M Scot | Chief Scientific Officer | May 21, 2018 | Option Exercise | $0.08 | 55,120 | 4,410 | 55,120 | May 23, 2018, 05:23 PM |
| Roberts M Scot | Chief Scientific Officer | Jun 06, 2017 | Buy | $4.42 | 449 | 1,985 | 449 | Feb 23, 2018, 04:21 PM |
| Enright William | President and CEO | Jan 02, 2018 | Option Exercise | $0.08 | 183,347 | 14,668 | 364,511 | Jan 04, 2018, 04:53 PM |
| SAYARE MITCHEL | Director | Dec 29, 2017 | Buy | $1.95 | 5,100 | 9,963 | 32,650 | Jan 03, 2018, 04:54 PM |
| SCHAFFER DERACE L | Director | Dec 29, 2017 | Buy | $1.93 | 38,699 | 74,778 | 589,453 | Jan 02, 2018, 05:09 PM |
| SCHAFFER DERACE L | Director | Dec 28, 2017 | Buy | $1.92 | 58,711 | 112,672 | 550,754 | Jan 02, 2018, 05:09 PM |
| SCHAFFER DERACE L | Director | Dec 27, 2017 | Buy | $1.77 | 77,706 | 137,210 | 492,043 | Dec 27, 2017, 06:27 PM |
| SCHAFFER DERACE L | Director | Dec 26, 2017 | Buy | $1.81 | 51,442 | 93,269 | 414,337 | Dec 27, 2017, 06:27 PM |
| SCHAFFER DERACE L | Director | Dec 22, 2017 | Buy | $1.61 | 17,982 | 28,877 | 362,895 | Dec 27, 2017, 06:27 PM |
| SCHAFFER DERACE L | Director | Dec 07, 2017 | Buy | $1.74 | 7,639 | 13,308 | 344,913 | Dec 08, 2017, 05:51 PM |
| SCHAFFER DERACE L | Director | Dec 06, 2017 | Buy | $1.80 | 16,106 | 28,996 | 337,274 | Dec 08, 2017, 05:51 PM |
| SCHAFFER DERACE L | Director | Dec 01, 2017 | Buy | $1.80 | 5,215 | 9,405 | 300,373 | Dec 05, 2017, 05:34 PM |
| SCHAFFER DERACE L | Director | Dec 05, 2017 | Buy | $1.78 | 13,495 | 23,987 | 321,168 | Dec 05, 2017, 05:34 PM |
| SCHAFFER DERACE L | Director | Dec 04, 2017 | Buy | $1.81 | 7,300 | 13,195 | 307,673 | Dec 05, 2017, 05:34 PM |
| SCHAFFER DERACE L | Director | Nov 30, 2017 | Buy | $1.84 | 12,978 | 23,816 | 295,158 | Nov 30, 2017, 05:38 PM |
| SCHAFFER DERACE L | Director | Nov 29, 2017 | Buy | $1.94 | 7,942 | 15,377 | 282,180 | Nov 30, 2017, 05:38 PM |
| SCHAFFER DERACE L | Director | Nov 28, 2017 | Buy | $1.97 | 12,395 | 24,445 | 274,238 | Nov 30, 2017, 05:38 PM |
| SCHAFFER DERACE L | Director | Nov 22, 2017 | Buy | $2.10 | 5,261 | 11,061 | 245,296 | Nov 27, 2017, 05:31 PM |
| SCHAFFER DERACE L | Director | Nov 27, 2017 | Buy | $2.00 | 10,042 | 20,060 | 261,843 | Nov 27, 2017, 05:31 PM |
| SCHAFFER DERACE L | Director | Nov 24, 2017 | Buy | $2.02 | 6,505 | 13,162 | 251,801 | Nov 27, 2017, 05:31 PM |
| SCHAFFER DERACE L | Director | Nov 21, 2017 | Buy | $2.06 | 7,236 | 14,905 | 240,035 | Nov 21, 2017, 06:10 PM |
| SCHAFFER DERACE L | Director | Nov 20, 2017 | Buy | $2.07 | 4,800 | 9,958 | 232,799 | Nov 21, 2017, 06:10 PM |
| SCHAFFER DERACE L | Director | Nov 17, 2017 | Buy | $2.12 | 6,295 | 13,352 | 227,999 | Nov 21, 2017, 06:10 PM |
| SCHAFFER DERACE L | Director | Aug 25, 2017 | Buy | $2.25 | 50,000 | 112,390 | 221,704 | Aug 28, 2017, 04:56 PM |
| SCHAFFER DERACE L | Director | Aug 24, 2017 | Buy | $2.24 | 17,326 | 38,892 | 171,704 | Aug 28, 2017, 04:56 PM |
| Drutz David | Director | Aug 23, 2017 | Buy | $2.27 | 5,000 | 11,339 | 30,777 | Aug 24, 2017, 04:48 PM |
| Drutz David | Director | Aug 22, 2017 | Buy | $2.15 | 5,000 | 10,757 | 25,777 | Aug 24, 2017, 04:48 PM |
| SCHAFFER DERACE L | Director | Aug 23, 2017 | Buy | $2.22 | 43,352 | 96,350 | 154,378 | Aug 23, 2017, 05:05 PM |
| SCHAFFER DERACE L | Director | Aug 22, 2017 | Buy | $2.10 | 5,958 | 12,519 | 111,026 | Aug 23, 2017, 05:05 PM |
| SCHAFFER DERACE L | Director | Aug 21, 2017 | Buy | $2.02 | 690 | 1,395 | 105,068 | Aug 23, 2017, 05:05 PM |
| Enright William | President and CEO | Aug 16, 2017 | Option Exercise | $0.08 | 163,377 | 13,070 | 181,164 | Aug 18, 2017, 04:45 PM |
| GILL JOHN | Director | Jun 02, 2017 | Buy | $4.34 | 1,000 | 4,344 | 83,224 | Jun 06, 2017, 04:49 PM |
| Runge Jeffrey W. | Director | Jan 20, 2017 | Option Exercise | $3.11 | 20,000 | 62,200 | 197,700 | Jan 24, 2017, 04:30 PM |
| SCHAFFER DERACE L | Director | Jan 13, 2017 | Option Exercise | $2.20 | 20,000 | 44,000 | 1,043,782 | Jan 17, 2017, 04:16 PM |
| St Peter Steven | Director | Jan 04, 2017 | Option Exercise | $2.59 | 70,000 | 181,500 | 205,004 | Jan 05, 2017, 04:31 PM |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | Dec 21, 2016 | Option Exercise | $1.67 | 22,657 | 37,861 | 126,346 | Dec 22, 2016, 04:15 PM |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Dec 09, 2016 | Sale | $3.26 | 436,324 | 1,422,416 | 6,626,403 | Dec 09, 2016, 04:54 PM |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Dec 08, 2016 | Sale | $3.25 | 440,479 | 1,431,557 | 7,062,727 | Dec 09, 2016, 04:54 PM |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Dec 07, 2016 | Sale | $3.26 | 477,829 | 1,557,723 | 7,503,206 | Dec 09, 2016, 04:54 PM |
| Runge Jeffrey W. | Director | Nov 28, 2016 | Option Exercise | $2.20 | 20,000 | 44,000 | 177,700 | Nov 30, 2016, 07:06 PM |
| GILL JOHN | President and CEO | Nov 22, 2016 | Option Exercise | $2.20 | 100,000 | 220,000 | 822,244 | Nov 23, 2016, 04:47 PM |
| SAYARE MITCHEL | Director | Nov 22, 2016 | Option Exercise | $2.09 | 270,500 | 564,845 | 275,500 | Nov 23, 2016, 04:47 PM |
| RICHMAN ERIC I | Director | Nov 22, 2016 | Option Exercise | $1.85 | 483,733 | 895,213 | 898,055 | Nov 23, 2016, 04:46 PM |
| SCHAFFER DERACE L | Director | Sep 30, 2016 | Option Exercise | $1.79 | 130,000 | 233,100 | 1,023,782 | Oct 04, 2016, 04:30 PM |
| RICHMAN ERIC I | Director | Sep 28, 2016 | Option Exercise | $1.45 | 237,500 | 343,625 | 414,322 | Sep 30, 2016, 04:33 PM |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | Sep 20, 2016 | Option Exercise | $1.63 | 53,689 | 87,725 | 103,689 | Sep 21, 2016, 05:09 PM |
| St Peter Steven | Director | Sep 16, 2016 | Option Exercise | $1.60 | 110,004 | 175,907 | 135,004 | Sep 20, 2016, 09:37 PM |
| Runge Jeffrey W. | Director | Sep 15, 2016 | Option Exercise | $1.54 | 120,000 | 184,800 | 157,700 | Sep 19, 2016, 09:47 PM |
| GILL JOHN | President and CEO | Sep 16, 2016 | Option Exercise | $2.51 | 30,000 | 75,300 | 722,244 | Sep 19, 2016, 06:00 PM |
| GILL JOHN | President and CEO | Sep 15, 2016 | Option Exercise | $1.55 | 80,000 | 124,000 | 692,244 | Sep 19, 2016, 06:00 PM |
| RICHMAN ERIC I | Director | Apr 13, 2016 | Option Exercise | $1.19 | 329,354 | 392,240 | 326,822 | Apr 15, 2016, 07:53 PM |
| RICHMAN ERIC I | Director | Apr 13, 2016 | Sale | $2.20 | 329,354 | 724,579 | 176,822 | Apr 15, 2016, 07:53 PM |
| RICHMAN ERIC I | Director | Apr 08, 2016 | Option Exercise | $1.76 | 6,400 | 11,264 | 183,222 | Apr 11, 2016, 06:18 PM |
| RICHMAN ERIC I | Director | Apr 07, 2016 | Option Exercise | $1.76 | 5,367 | 9,446 | 182,189 | Apr 11, 2016, 06:18 PM |
| RICHMAN ERIC I | Director | Apr 08, 2016 | Sale | $2.20 | 6,400 | 14,080 | 176,822 | Apr 11, 2016, 06:18 PM |
| RICHMAN ERIC I | Director | Apr 07, 2016 | Sale | $2.20 | 5,367 | 11,807 | 176,822 | Apr 11, 2016, 06:18 PM |
| St Peter Steven | Director | Mar 19, 2015 | Buy | $1.65 | 25,000 | 41,212 | 25,000 | Mar 23, 2015, 05:28 PM |
| CHANG LINDA L | SVP, CFO & Secretary | Jan 07, 2015 | Option Exercise | $1.13 | 29,600 | 33,448 | 59,600 | Jan 09, 2015, 07:00 PM |
| CHANG LINDA L | SVP, CFO & Secretary | Jan 07, 2015 | Sale | $2.10 | 29,600 | 62,160 | 30,000 | Jan 09, 2015, 07:00 PM |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | Sep 22, 2014 | Buy | $1.55 | 15,000 | 23,185 | 7,981,035 | Sep 24, 2014, 06:02 PM |
| Cook Francesca M | SVP, Policy & Gov't Affairs | Jan 21, 2012 | Option Exercise | $1.30 | 3,059 | 3,977 | 37,631 | Jan 24, 2012, 09:10 PM |
| Karp Jordan P | SVP, General Counsel | Dec 30, 2011 | Option Exercise | $1.27 | 7,863 | 9,986 | 21,929 | Jan 04, 2012, 05:24 PM |
| Runge Jeffrey W. | Director | Dec 12, 2011 | Buy | $1.30 | 20,000 | 26,000 | 20,000 | Dec 14, 2011, 08:07 PM |
| FUERST THOMAS RICHARD | SVP, Chief Scientific Officer | Nov 22, 2011 | Buy | $1.27 | 5,000 | 6,350 | 15,000 | Nov 23, 2011, 01:52 PM |
| CHANG LINDA L | SVP & CFO | Nov 16, 2011 | Buy | $1.38 | 10,000 | 13,842 | 30,000 | Nov 18, 2011, 12:43 PM |
| FUERST THOMAS RICHARD | EVP, Chief Scientific Officer | Nov 10, 2011 | Buy | $1.51 | 10,000 | 15,098 | 10,000 | Nov 14, 2011, 06:56 AM |
| Karp Jordan P | SVP, General Counsel | Nov 10, 2011 | Buy | $1.51 | 10,000 | 15,064 | 10,000 | Nov 14, 2011, 06:54 AM |
| RICHMAN ERIC I | President and CEO | Nov 10, 2011 | Buy | $1.50 | 10,000 | 15,025 | 4,500 | Nov 14, 2011, 06:51 AM |
| SCHAFFER DERACE L | Director | Aug 25, 2011 | Buy | $0.70 | 16,800 | 11,760 | 1,055,413 | Aug 26, 2011, 04:58 PM |
| SCHAFFER DERACE L | Director | Aug 24, 2011 | Buy | $0.70 | 20,902 | 14,631 | 1,038,613 | Aug 26, 2011, 04:58 PM |
| SAYARE MITCHEL | Director | Aug 18, 2011 | Buy | $2.17 | 5,000 | 10,850 | 5,000 | Aug 19, 2011, 11:04 AM |
| Runge Jeffrey W. | Director | Jun 17, 2011 | Buy | $2.69 | 17,850 | 48,072 | 17,850 | Jun 20, 2011, 05:13 PM |
| Riddle Valerie D | SVP, Medical Director | May 25, 2011 | Option Exercise | $2.96 | 4,775 | 14,134 | 54,565 | Jun 01, 2011, 09:12 PM |
| Riddle Valerie D | SVP, Medical Director | May 31, 2011 | Option Exercise | $2.46 | 3,438 | 8,457 | 53,228 | Jun 01, 2011, 09:12 PM |
| Riddle Valerie D | SVP, Medical Director | May 25, 2011 | Sale | $3.75 | 4,775 | 17,906 | 49,790 | Jun 01, 2011, 09:12 PM |
| Riddle Valerie D | SVP, Medical Director | May 31, 2011 | Sale | $4.01 | 8,792 | 35,222 | 49,790 | Jun 01, 2011, 09:12 PM |
| PAPPAJOHN JOHN | Director | May 25, 2011 | Sale | $3.68 | 50,000 | 184,135 | 394,044 | May 27, 2011, 06:12 PM |
| Riddle Valerie D | SVP, Medical Director | May 23, 2011 | Option Exercise | $2.46 | 3,438 | 8,457 | 56,761 | May 25, 2011, 09:25 PM |
| Riddle Valerie D | SVP, Medical Director | May 23, 2011 | Sale | $3.65 | 8,791 | 32,082 | 53,323 | May 25, 2011, 09:25 PM |
| SCHAFFER DERACE L | Director | May 17, 2011 | Sale | $3.71 | 75,000 | 278,340 | 1,210,208 | May 19, 2011, 06:16 PM |
| SCHAFFER DERACE L | Director | May 19, 2011 | Sale | $3.68 | 142,497 | 524,688 | 1,017,711 | May 19, 2011, 06:16 PM |
| SCHAFFER DERACE L | Director | May 18, 2011 | Sale | $3.68 | 50,000 | 183,940 | 1,160,208 | May 19, 2011, 06:16 PM |
| RICHMAN ERIC I | See Remarks | Mar 23, 2010 | Option Exercise | $3.40 | 10,500 | 35,700 | 99,322 | May 12, 2011, 06:55 PM |
| RICHMAN ERIC I | See Remarks | Jan 21, 2011 | Option Exercise | $3.42 | 3,057 | 10,455 | 109,822 | Jan 25, 2011, 05:00 PM |
| Cook Francesca M | VP, Policy & GVMNT Affairs | Jan 21, 2011 | Option Exercise | $3.42 | 2,574 | 8,803 | 40,690 | Jan 25, 2011, 04:58 PM |
| Riddle Valerie D | VP, Medical Director | Jan 21, 2011 | Option Exercise | $3.42 | 2,750 | 9,405 | 53,323 | Jan 25, 2011, 04:57 PM |
| SCHAFFER DERACE L | Director | Nov 24, 2010 | Option Exercise | $2.54 | 444,044 | 1,128,582 | 1,285,208 | Nov 29, 2010, 09:56 PM |
| PAPPAJOHN JOHN | Director | Nov 22, 2010 | Option Exercise | $2.54 | 444,044 | 1,128,582 | 444,044 | Nov 29, 2010, 09:55 PM |
| McCleary Joel | Director | Nov 03, 2010 | Option Exercise | $2.54 | 18,757 | 47,675 | 120,167 | Nov 05, 2010, 08:33 PM |
| RICHMAN ERIC I | President and CEO | Nov 03, 2010 | Option Exercise | $2.54 | 7,306 | 18,570 | 77,879 | Nov 05, 2010, 08:32 PM |
| MPM BIOVENTURES III LLC | 10% Owner | Nov 03, 2010 | Option Exercise | $2.54 | 2,428,171 | 6,171,682 | 5,917,614 | Nov 05, 2010, 04:02 PM |
| MPM BIOVENTURES III LLC | 10% Owner | Nov 03, 2010 | Buy | $3.50 | 430,000 | 1,505,000 | 6,347,614 | Nov 05, 2010, 04:02 PM |
| EVNIN LUKE | 10% Owner | Nov 03, 2010 | Option Exercise | $2.54 | 2,428,171 | 6,171,682 | 5,917,614 | Nov 05, 2010, 03:59 PM |
| EVNIN LUKE | 10% Owner | Nov 03, 2010 | Buy | $3.50 | 430,000 | 1,505,000 | 6,347,614 | Nov 05, 2010, 03:59 PM |
| HEALTHCARE VENTURES VII LP | 10% Owner | Nov 03, 2010 | Option Exercise | $2.54 | 935,814 | 2,378,558 | 4,253,057 | Nov 05, 2010, 10:55 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Drutz David | Director | 08/19/2024 | 106,375 |
| Drutz David | Director | 08/19/2024 | 110,547 |
| Shutterly Andrew | Acting Chief Financial Officer | 07/31/2024 | 6,811 |
| Roberts M Scot | Chief Scientific Officer | 07/31/2024 | 3,516 |
| Jordt Raymond M | Chief Business Officer | 07/31/2024 | 4,961 |
| Harris Matthew Scott | Chief Medical Officer | 07/31/2024 | 8,039 |
| Roberts M Scot | Chief Scientific Officer | 02/02/2024 | 21,716 |
| Roberts M Scot | Chief Scientific Officer | 02/01/2024 | 17,794 |
| Harris Matthew Scott | Chief Medical Officer | 02/02/2024 | 21,734 |
| Harris Matthew Scott | Chief Medical Officer | 02/01/2024 | 17,794 |
| Garg Vipin K | President and CEO | 02/01/2024 | 72,252 |
| Garg Vipin K | President and CEO | 02/02/2024 | 78,064 |
| Roberts M Scot | Chief Scientific Officer | 01/31/2024 | 15,763 |
| Roberts M Scot | Chief Scientific Officer | 01/30/2024 | 26,548 |
| Jordt Raymond M | Chief Business Officer | 01/31/2024 | 13,531 |
| Harris Matthew Scott | Chief Medical Officer | 01/31/2024 | 8,761 |
| Harris Matthew Scott | Chief Medical Officer | 01/30/2024 | 26,548 |
| Garg Vipin K | President and CEO | 01/31/2024 | 21,221 |
| Garg Vipin K | President and CEO | 01/30/2024 | 114,631 |
| Eisenstadt Richard I | Chief Financial Officer | 01/31/2024 | 12,430 |
| Eisenstadt Richard I | Chief Financial Officer | 01/30/2024 | 21,315 |
| Jordt Raymond M | Chief Business Officer | 01/01/2024 | 28,159 |
| Eisenstadt Richard I | Chief Financial Officer | 12/29/2023 | 34,245 |
| Drutz David | Director | 08/15/2023 | 863 |
| Garg Vipin K | President and CEO | 07/31/2023 | 354 |
| Eisenstadt Richard I | Chief Financial Officer | 07/31/2023 | 5,128 |
| Harris Matthew Scott | Chief Medical Officer | 07/31/2023 | 1,942 |
| Roberts M Scot | Chief Scientific Officer | 07/31/2023 | 1,596 |
| Jordt Raymond M | Chief Business Officer | 07/31/2023 | 5,148 |
| GILL JOHN | Director | 08/12/2022 | 40,710 |
| Drutz David | Director | 03/23/2023 | 38,430 |
| Eisenstadt Richard I | Chief Financial Officer | 03/24/2023 | 43,140 |
| Harris Matthew Scott | Chief Medical Officer | 03/23/2023 | 42,200 |
| Roberts M Scot | Chief Scientific Officer | 02/02/2023 | 35,720 |
| Harris Matthew Scott | Chief Medical Officer | 02/02/2023 | 35,555 |
| Garg Vipin K | President and CEO | 02/02/2023 | 126,667 |
| Roberts M Scot | Chief Scientific Officer | 01/31/2023 | 14,659 |
| Roberts M Scot | Chief Scientific Officer | 02/01/2023 | 30,082 |
| Harris Matthew Scott | Chief Medical Officer | 01/31/2023 | 13,230 |
| Harris Matthew Scott | Chief Medical Officer | 02/01/2023 | 30,082 |
| Garg Vipin K | President and CEO | 01/31/2023 | 19,784 |
| Garg Vipin K | President and CEO | 02/01/2023 | 105,527 |
| Eisenstadt Richard I | Chief Financial Officer | 01/31/2023 | 11,964 |
| Eisenstadt Richard I | Chief Financial Officer | 12/31/2022 | 49,811 |
| Pisano Wayne | Director | 12/22/2022 | 52,000 |
| Pisano Wayne | Director | 12/22/2022 | 300,268 |
| Garg Vipin K | President and CEO | 11/30/2022 | 29,920 |
| Drutz David | Director | 11/18/2022 | 334 |
| Garg Vipin K | President and CEO | 10/30/2022 | 38,399 |
| Garg Vipin K | President and CEO | 09/30/2022 | 38,412 |
| Garg Vipin K | President and CEO | 08/30/2022 | 56,953 |
| Garg Vipin K | President and CEO | 08/31/2022 | 400,322 |
| Garg Vipin K | President and CEO | 08/12/2022 | 225,890 |
| Harris Matthew Scott | Chief Medical Officer | 07/31/2022 | 7,381 |
| Roberts M Scot | Chief Scientific Officer | 07/31/2022 | 5,022 |
| Eisenstadt Richard I | Chief Financial Officer | 07/31/2022 | 9,371 |
| Garg Vipin K | President and CEO | 07/30/2022 | 36,114 |
| Roberts M Scot | Chief Scientific Officer | 07/01/2022 | 78,190 |
| Roberts M Scot | Chief Scientific Officer | 07/05/2022 | 2,322 |
| Roberts M Scot | Chief Scientific Officer | 07/01/2022 | 323,784 |
| Roberts M Scot | Chief Scientific Officer | 07/05/2022 | 122,184 |
| Garg Vipin K | President and CEO | 06/30/2022 | 35,182 |
| Roberts M Scot | Chief Scientific Officer | 06/29/2022 | 14,201 |
| Roberts M Scot | Chief Scientific Officer | 06/29/2022 | 65,546 |
| Roberts M Scot | Chief Scientific Officer | 06/27/2022 | 79,752 |
| Roberts M Scot | Chief Scientific Officer | 06/27/2022 | 448,254 |
| Jorkasky Diane | Director | 06/27/2022 | 55,472 |
| Jorkasky Diane | Director | 06/27/2022 | 206,944 |
| Schafer Klaus | Director | 06/20/2022 | 670 |
| Drutz David | Director | 06/15/2022 | 8,000 |
| Garg Vipin K | President and CEO | 05/30/2022 | 15,130 |
| Drutz David | Director | 05/24/2022 | 5,400 |
| Garg Vipin K | President and CEO | 04/30/2022 | 13,596 |
| Garg Vipin K | President and CEO | 03/30/2022 | 18,192 |
| Harris Matthew Scott | Chief Medical Officer | 02/28/2022 | 57,639 |
| Harris Matthew Scott | Chief Medical Officer | 02/28/2022 | 225,600 |
| Garg Vipin K | President and CEO | 02/28/2022 | 22,282 |
| Harris Matthew Scott | Chief Medical Officer | 01/31/2022 | 12,348 |
| Harris Matthew Scott | Chief Medical Officer | 02/01/2022 | 17,420 |
| Garg Vipin K | President and CEO | 01/31/2022 | 18,913 |
| Garg Vipin K | President and CEO | 02/01/2022 | 61,087 |
| Roberts M Scot | Chief Scientific Officer | 01/31/2022 | 14,447 |
| Roberts M Scot | Chief Scientific Officer | 02/01/2022 | 17,420 |
| Garg Vipin K | President and CEO | 01/30/2022 | 16,956 |
| Drutz David | Director | 01/25/2022 | 168 |
| Garg Vipin K | President and CEO | 12/30/2021 | 26,853 |
| Drutz David | Director | 12/14/2021 | 334 |
| Garg Vipin K | President and CEO | 11/30/2021 | 31,543 |
| Drutz David | Director | 11/19/2021 | 168 |
| Garg Vipin K | President and CEO | 10/30/2021 | 32,476 |
| Garg Vipin K | President and CEO | 09/30/2021 | 34,009 |
| Garg Vipin K | President and CEO | 08/30/2021 | 42,383 |
| Harris Matthew Scott | Chief Medical Officer | 07/31/2021 | 5,589 |
| Brown William Michael | Chief Financial Officer | 07/31/2021 | 6,191 |
| Roberts M Scot | Chief Scientific Officer | 07/31/2021 | 13,492 |
| Garg Vipin K | President and CEO | 07/30/2021 | 27,273 |
| Garg Vipin K | President and CEO | 06/30/2021 | 29,619 |
| Garg Vipin K | President and CEO | 03/30/2021 | 27,073 |
| Hodges Philip | Director | 03/01/2021 | 96,480 |
| Garg Vipin K | President and CEO | 02/28/2021 | 31,848 |
| Harris Matthew Scott | Chief Medical Officer | 01/31/2021 | 11,752 |
| Roberts M Scot | Chief Scientific Officer | 01/31/2021 | 5,669 |
| Brown William Michael | Chief Financial Officer | 01/31/2021 | 11,375 |
| Garg Vipin K | President and CEO | 01/31/2021 | 12,808 |
| Garg Vipin K | President and CEO | 01/30/2021 | 33,601 |
| Garg Vipin K | President and CEO | 12/30/2020 | 34,183 |
| Schafer Klaus | Director | 12/10/2020 | 23,980 |
| Hodges Philip | Director | 12/01/2020 | 16,614 |
| Hodges Philip | Director | 11/30/2020 | 30,000 |
| Garg Vipin K | President and CEO | 11/30/2020 | 27,432 |
| GILL JOHN | Director | 11/30/2020 | 100,426 |
| Drutz David | Director | 11/13/2020 | 144 |
| Schafer Klaus | Director | 11/12/2020 | 100,586 |
| Pisano Wayne | Director | 11/12/2020 | 102,485 |
| Harris Matthew Scott | Director | 11/12/2020 | 40,230 |
| Garg Vipin K | President and CEO | 10/30/2020 | 23,072 |
| Garg Vipin K | President & CEO | 09/30/2020 | 26,598 |
| Garg Vipin K | President & CEO | 08/30/2020 | 35,504 |
| Harris Matthew Scott | Chief Medical Officer | 07/31/2020 | 11,803 |
| Brown William Michael | Chief Financial Officer | 07/31/2020 | 11,563 |
| Roberts M Scot | Chief Scientific Officer | 07/31/2020 | 5,634 |
| Garg Vipin K | Chief Financial Officer | 07/31/2020 | 17,044 |
| Garg Vipin K | President and CEO | 07/30/2020 | 52,511 |
| Garg Vipin K | President and CEO | 06/30/2020 | 21,581 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 06/15/2020 | 11,310,000 |
| Garg Vipin K | President and CEO | 05/30/2020 | 18,699 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 05/28/2020 | 1,757,090 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 05/27/2020 | 3,098,761 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | 05/26/2020 | 6,539,641 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Owner | 05/14/2020 | 814,708 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Owner | 05/15/2020 | 142,392 |
| Garg Vipin K | President and CEO | 04/30/2020 | 6,146 |
| Garg Vipin K | President and CEO | 03/31/2020 | 6,088 |
| Garg Vipin K | President and CEO | 02/29/2020 | 7,456 |
| Brown William Michael | Chief Financial Officer | 01/31/2020 | 11,769 |
| Garg Vipin K | President and CEO | 01/31/2020 | 16,482 |
| Roberts M Scot | Chief Scientific Officer | 01/31/2020 | 5,399 |
| Garg Vipin K | President and CEO | 01/30/2020 | 3,567 |
| Garg Vipin K | President and CEO | 12/30/2019 | 3,598 |
| Garg Vipin K | President and CEO | 11/30/2019 | 43,636 |
| Garg Vipin K | President and CEO | 09/05/2019 | 42,000 |
| Pisano Wayne | Director | 10/09/2018 | 9,180 |
| Enright William | President and CEO | 05/25/2018 | 660 |
| Roberts M Scot | Chief Scientific Officer | 05/21/2018 | 4,410 |
| Roberts M Scot | Chief Scientific Officer | 06/06/2017 | 1,985 |
| Enright William | President and CEO | 01/02/2018 | 14,668 |
| SAYARE MITCHEL | Director | 12/29/2017 | 9,963 |
| SCHAFFER DERACE L | Director | 12/29/2017 | 74,778 |
| SCHAFFER DERACE L | Director | 12/28/2017 | 112,672 |
| SCHAFFER DERACE L | Director | 12/27/2017 | 137,210 |
| SCHAFFER DERACE L | Director | 12/26/2017 | 93,269 |
| SCHAFFER DERACE L | Director | 12/22/2017 | 28,877 |
| SCHAFFER DERACE L | Director | 12/07/2017 | 13,308 |
| SCHAFFER DERACE L | Director | 12/06/2017 | 28,996 |
| SCHAFFER DERACE L | Director | 12/01/2017 | 9,405 |
| SCHAFFER DERACE L | Director | 12/05/2017 | 23,987 |
| SCHAFFER DERACE L | Director | 12/04/2017 | 13,195 |
| SCHAFFER DERACE L | Director | 11/30/2017 | 23,816 |
| SCHAFFER DERACE L | Director | 11/29/2017 | 15,377 |
| SCHAFFER DERACE L | Director | 11/28/2017 | 24,445 |
| SCHAFFER DERACE L | Director | 11/22/2017 | 11,061 |
| SCHAFFER DERACE L | Director | 11/27/2017 | 20,060 |
| SCHAFFER DERACE L | Director | 11/24/2017 | 13,162 |
| SCHAFFER DERACE L | Director | 11/21/2017 | 14,905 |
| SCHAFFER DERACE L | Director | 11/20/2017 | 9,958 |
| SCHAFFER DERACE L | Director | 11/17/2017 | 13,352 |
| SCHAFFER DERACE L | Director | 08/25/2017 | 112,390 |
| SCHAFFER DERACE L | Director | 08/24/2017 | 38,892 |
| Drutz David | Director | 08/23/2017 | 11,339 |
| Drutz David | Director | 08/22/2017 | 10,757 |
| SCHAFFER DERACE L | Director | 08/23/2017 | 96,350 |
| SCHAFFER DERACE L | Director | 08/22/2017 | 12,519 |
| SCHAFFER DERACE L | Director | 08/21/2017 | 1,395 |
| Enright William | President and CEO | 08/16/2017 | 13,070 |
| GILL JOHN | Director | 06/02/2017 | 4,344 |
| Runge Jeffrey W. | Director | 01/20/2017 | 62,200 |
| SCHAFFER DERACE L | Director | 01/13/2017 | 44,000 |
| St Peter Steven | Director | 01/04/2017 | 181,500 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 12/21/2016 | 37,861 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | 12/09/2016 | 1,422,416 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | 12/08/2016 | 1,431,557 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | 12/07/2016 | 1,557,723 |
| Runge Jeffrey W. | Director | 11/28/2016 | 44,000 |
| GILL JOHN | President and CEO | 11/22/2016 | 220,000 |
| SAYARE MITCHEL | Director | 11/22/2016 | 564,845 |
| RICHMAN ERIC I | Director | 11/22/2016 | 895,213 |
| SCHAFFER DERACE L | Director | 09/30/2016 | 233,100 |
| RICHMAN ERIC I | Director | 09/28/2016 | 343,625 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 09/20/2016 | 87,725 |
| St Peter Steven | Director | 09/16/2016 | 175,907 |
| Runge Jeffrey W. | Director | 09/15/2016 | 184,800 |
| GILL JOHN | President and CEO | 09/16/2016 | 75,300 |
| GILL JOHN | President and CEO | 09/15/2016 | 124,000 |
| RICHMAN ERIC I | Director | 04/13/2016 | 392,240 |
| RICHMAN ERIC I | Director | 04/13/2016 | 724,579 |
| RICHMAN ERIC I | Director | 04/08/2016 | 11,264 |
| RICHMAN ERIC I | Director | 04/07/2016 | 9,446 |
| RICHMAN ERIC I | Director | 04/08/2016 | 14,080 |
| RICHMAN ERIC I | Director | 04/07/2016 | 11,807 |
| St Peter Steven | Director | 03/19/2015 | 41,212 |
| CHANG LINDA L | SVP, CFO & Secretary | 01/07/2015 | 33,448 |
| CHANG LINDA L | SVP, CFO & Secretary | 01/07/2015 | 62,160 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% Owner | 09/22/2014 | 23,185 |
| Cook Francesca M | SVP, Policy & Gov't Affairs | 01/21/2012 | 3,977 |
| Karp Jordan P | SVP, General Counsel | 12/30/2011 | 9,986 |
| Runge Jeffrey W. | Director | 12/12/2011 | 26,000 |
| FUERST THOMAS RICHARD | SVP, Chief Scientific Officer | 11/22/2011 | 6,350 |
| CHANG LINDA L | SVP & CFO | 11/16/2011 | 13,842 |
| FUERST THOMAS RICHARD | EVP, Chief Scientific Officer | 11/10/2011 | 15,098 |
| Karp Jordan P | SVP, General Counsel | 11/10/2011 | 15,064 |
| RICHMAN ERIC I | President and CEO | 11/10/2011 | 15,025 |
| SCHAFFER DERACE L | Director | 08/25/2011 | 11,760 |
| SCHAFFER DERACE L | Director | 08/24/2011 | 14,631 |
| SAYARE MITCHEL | Director | 08/18/2011 | 10,850 |
| Runge Jeffrey W. | Director | 06/17/2011 | 48,072 |
| Riddle Valerie D | SVP, Medical Director | 05/25/2011 | 14,134 |
| Riddle Valerie D | SVP, Medical Director | 05/31/2011 | 8,457 |
| Riddle Valerie D | SVP, Medical Director | 05/25/2011 | 17,906 |
| Riddle Valerie D | SVP, Medical Director | 05/31/2011 | 35,222 |
| PAPPAJOHN JOHN | Director | 05/25/2011 | 184,135 |
| Riddle Valerie D | SVP, Medical Director | 05/23/2011 | 8,457 |
| Riddle Valerie D | SVP, Medical Director | 05/23/2011 | 32,082 |
| SCHAFFER DERACE L | Director | 05/17/2011 | 278,340 |
| SCHAFFER DERACE L | Director | 05/19/2011 | 524,688 |
| SCHAFFER DERACE L | Director | 05/18/2011 | 183,940 |
| RICHMAN ERIC I | See Remarks | 03/23/2010 | 35,700 |
| RICHMAN ERIC I | See Remarks | 01/21/2011 | 10,455 |
| Cook Francesca M | VP, Policy & GVMNT Affairs | 01/21/2011 | 8,803 |
| Riddle Valerie D | VP, Medical Director | 01/21/2011 | 9,405 |
| SCHAFFER DERACE L | Director | 11/24/2010 | 1,128,582 |
| PAPPAJOHN JOHN | Director | 11/22/2010 | 1,128,582 |
| McCleary Joel | Director | 11/03/2010 | 47,675 |
| RICHMAN ERIC I | President and CEO | 11/03/2010 | 18,570 |
| MPM BIOVENTURES III LLC | 10% Owner | 11/03/2010 | 6,171,682 |
| MPM BIOVENTURES III LLC | 10% Owner | 11/03/2010 | 1,505,000 |
| EVNIN LUKE | 10% Owner | 11/03/2010 | 6,171,682 |
| EVNIN LUKE | 10% Owner | 11/03/2010 | 1,505,000 |
| HEALTHCARE VENTURES VII LP | 10% Owner | 11/03/2010 | 2,378,558 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ALTIMMUNE, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 5,321,089 | 0.0008% | 31.64% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,593,810 | 0.00093% | 28.87% | Other |
| D. E. SHAW & CO., INC. | 762,362 | 0.00474% | 115.14% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 27,600 | 0.00087% | -94.13% | Event Driven, Value |
| AQR CAPITAL MANAGEMENT LLC | 41,379 | 0.00042% | -31.82% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000 | 0.02% | -29.57% | Value |
| ALPS ADVISORS INC | 55,304 | 0.00252% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR ALTIMMUNE, INC.
STOCK BUYBACKS FOR ALTIMMUNE, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
0.17%
1Q
12/31/2023
21.24%
2Q
09/30/2023
32.24%
3Q
06/30/2023
39.91%
4Q
03/31/2023
41.49%
5Q
12/31/2022
41.68%
6Q
09/30/2022
43.90%
7Q
06/30/2022
49.31%
8Q
03/31/2022
61.30%
9Q
12/31/2021
66.48%
10Q
09/30/2021
71.44%
11Q
06/30/2021
71.49%
12Q
03/31/2021
82.25%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALTIMMUNE, INC.
LOADING...